DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-4.53%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$99.1M
AUM Growth
+$99.1M
(-6%)
Cap. Flow
+$6.84M
Cap. Flow
% of AUM
6.9%
Top 10 Holdings %
Top 10 Hldgs %
58.86%
Holding
65
New
16
Increased
6
Reduced
8
Closed
6
Top Buys
| 1 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$3.9M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.01M |
| 3 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$2.52M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.67M |
| 5 |
Neurocrine Biosciences
NBIX
|
$1.04M |
Top Sells
| 1 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
$4.42M |
| 2 |
VXRT
Vaxart
VXRT
|
$2.08M |
| 3 |
Arcturus Therapeutics
ARCT
|
$1.47M |
| 4 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$1.42M |
| 5 |
Galmed Pharmaceuticals
GLMD
|
$766K |
Sector Composition
| 1 | Healthcare | 55.18% |
| 2 | Financials | 1.1% |
